PAPER Taguchi Y, Schätzl HM
SEARCH RESULTS
330988 RESULTS
PAPER Abskharon RN, Giachin G, Wohlkonig A, Soror SH, Pardon E, Legname G, Steyaert J
Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a nanobody.
J Am Chem Soc. 2014 Jan 22;136(3):937-44. Epub 2014 Jan 8 PubMed: 24400836PAPER Nyström S, Hammarström P
Is the prevalent human prion protein 129M/V mutation a living fossil from a Paleolithic panzootic superprion pandemic?
Prion. 2014 Jan 7;8(1) PubMed: 24398570PAPER Sheng K, Fang W, Su M, Li R, Zou D, Han Y, Wang X, Cheng O
Altered spontaneous brain activity in patients with Parkinson's disease accompanied by depressive symptoms, as revealed by regional homogeneity and functional connectivity in the prefrontal-limbic system.
PLoS One. 2014;9(1):e84705. Epub 2014 Jan 3 PubMed: 24404185PAPER Petersen CM, Nelson R, Steffen TM
The Effect of Parkinson Drug Timing on Cardiovascular Response during Treadmill Exercise in a Person with Parkinson Disease and Freezing of Gait.
Physiother Can. 2013;65(3):217-22. PubMed: 24403689PAPER Dujardin K, Lopes R
Apathy and impaired recognition of emotion: are they related in Parkinson's disease?
J Neurol Neurosurg Psychiatry. 2014 Jan 8; PubMed: 24403281PAPER Robert G, Le Jeune F, Dondaine T, Drapier S, Péron J, Lozachmeur C, Sauleau P, Houvenaghel JF, Travers D, Millet B, Vérin M, Drapier D
Apathy and impaired emotional facial recognition networks overlap in Parkinson's disease: a PET study with conjunction analyses.
J Neurol Neurosurg Psychiatry. 2014 Jan 8; PubMed: 24403280PAPER Skibinski G, Nakamura K, Cookson MR, Finkbeiner S
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies.
J Neurosci. 2014 Jan 8;34(2):418-33. PubMed: 24403142PAPER Kelsey JE, Neville C
The effects of the β-lactam antibiotic, ceftriaxone, on forepaw stepping and L-DOPA-induced dyskinesia in a rodent model of Parkinson's disease.
Psychopharmacology (Berl). 2014 Jun;231(12):2405-15. Epub 2014 Jan 9 PubMed: 24402134PAPER Sauerbier A, Ray Chaudhuri K
Non-motor symptoms: the core of multi-morbid Parkinson's disease.
Br J Hosp Med (Lond). 2014 Jan;75(1):18-24. PubMed: 24401966PAPER Trost N, Cook M, Hammersley E, Bui MQ, Brotchie P, Burgess T, Slater H, Storey E, Loesch DZ
White Matter Changes in Patients with Parkinson's Disease Carrying Small CGG Expansion FMR1 Alleles: A Pilot Study.
Neurodegener Dis. 2013 Dec 24; PubMed: 24401315PAPER Darbin O, Adams E, Martino A, Naritoku L, Dees D, Naritoku D
Non-linear dynamics in parkinsonism.
Front Neurol. 2013 Dec 25;4:211. PubMed: 24399994PAPER Jahanshahi M
Effects of deep brain stimulation of the subthalamic nucleus on inhibitory and executive control over prepotent responses in Parkinson's disease.
Front Syst Neurosci. 2013 Dec 25;7:118. PubMed: 24399941PAPER Saitoh K, Abe K, Chiba T, Katagiri N, Saitoh T, Horiguchi Y, Nojima H, Taguchi K
Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
Pharmacol Rep. 2013;65(5):1204-12. PubMed: 24399716PAPER Konieczny J, Lenda T
Contribution of the mGluR7 receptor to antiparkinsonian-like effects in rats: a behavioral study with the selective agonist AMN082.
Pharmacol Rep. 2013;65(5):1194-203. PubMed: 24399715Current Filters
No filters selected